Validation and Compliance

Apr 01, 2011
BioPharm International
Courts and Congress seek to reshape policies and programs affecting drug costs and access.
Mar 01, 2011
BioPharm International
As drug shortages make headlines, FDA tests the Sentinel safety system and its effect on healthcare.
Mar 01, 2011
BioPharm International
By BioPharm International Editors
Executive management leadership is essential in the effective implementation of QbD.
Feb 01, 2011
BioPharm International
FDA prepares for top-level changes while promoting transparency and product safety
Jan 01, 2011
BioPharm International
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
Dec 01, 2010
BioPharm International
Changes on Capital Hill create uncertainty for healthcare reform, drug regulation, and biomedical research.
Nov 01, 2010
BioPharm International
Comparative effectiveness poses challenges for drug manufacturers.
Nov 01, 2010
BioPharm International
By BioPharm International Editors
Best practices to strengthen supplier quality management.
Oct 01, 2010
BioPharm International
A new strategy to streamline vaccine development and oversight.
Sep 01, 2010
BioPharm International
By BioPharm International Editors
What small biotechs need to know about quality management systems.
native1_300x100
lorem ipsum